With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate, currently in clinical ...

Gary Ellsworth, Head of North America Alliance Management, IQVIA shares insight on key trends driving outsourcing in today’s ...

Genentech, a member of the Roche Group, has broken ground on its newest U.S. manufacturing site in Holly Springs, North ...

Adva Biotechnology Ltd. and Autolomous Ltd. have joined forces to co-lead an early adopter initiative focused on digitizing, ...

The company expands its API facility in Waltham, MA, to support the development and manufacturing of peptide therapies.

The United States Food and Drug Administration (FDA) has suspended Valneva SE’s license for IXCHIQ, citing four new reports ...

Incyte has appointed Soni Basi as Executive Vice President and Chief Human Resources Officer (CHRO) effective August 25, 2025 ...

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...

Thermo Fisher Scientific Inc. has opened its manufacturing center of excellence facility in Mebane, North Carolina.

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...